Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2013; 19(39): 6548-6554
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6548
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6548
Figure 1 Example of strategy using a semi-automated 3D volumetry system.
Hepavision® MEVIS. A: 3D volumetry before associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): future liver remnant (FLR) 26%; B: Two weeks after ALPPS volumetry of FLR: 43% (increase of 65%).
- Citation: Donati M, Stavrou GA, Oldhafer KJ. Current position of ALPPS in the surgical landscape of CRLM treatment proposals. World J Gastroenterol 2013; 19(39): 6548-6554
- URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6548.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6548